维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09887 维立志博-B

未开盘 12-23 16:08:09

51.100

+1.600

+3.23%

最高51.100	最低48.200	成交量54.84万
今开49.540	昨收49.500	日振幅5.86%
总市值101.69亿	流通市值78.18亿	总股本1.99亿
成交额2,712万	换手率0.36%	流通股本1.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"维立志博-B","latestPrice":51.1,"timestamp":1766477289006,"preClose":49.5,"halted":0,"volume":548411,"delay":0,"floatShares":153000000,"shares":199000000,"eps":-2.008042,"marketStatus":"未开盘","change":1.6,"latestTime":"12-23 16:08:09","open":49.54,"high":51.1,"low":48.2,"amount":27123673,"amplitude":0.058586,"askPrice":51.15,"askSize":200,"bidPrice":51.1,"bidSize":3400,"shortable":3,"etf":0,"ttmEps":-1.858667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":49.5,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":1.2226759480689449,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09887","defaultTab":"news","newsList":[{"id":"1141035379","title":"维立志博与Dianthus Therapeutics宣布启动LBL-047（DNTH212）在健康志愿者和系统性红斑狼疮患者中的一期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1141035379","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141035379?lang=zh_cn&edition=full","pubTime":"2025-12-23 19:15","pubTimestamp":1766488533,"startTime":"0","endTime":"0","summary":"12月23日讯 - 南京维立志博（9887.HK）::*维立志博与Dianthus Therapeutics宣布启动LBL-047（DNTH212）在健康志愿者和系统性红斑狼疮（SLE）患者中的一期临床试验*南京维立志博有限公司：预计在2026年下半年公布健康志愿者的主要结果。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","HK0000500386.USD","BK1161","BK4139","HK0000252160.HKD","DNTH","HK0000252152.HKD"],"gpt_icon":0},{"id":"2593849898","title":"维立志博-B(09887)：LBL-024于铂耐药卵巢癌IB/II期试验的首例患者用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2593849898","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593849898?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:32","pubTimestamp":1766478731,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，评价奥帕替苏米单抗(PD-L1/4-1BB双特异性抗体LBL-024)用于治疗铂耐药卵巢癌的Ib/II期临床研究首例患者已成功用药。本次开展的开放标签、多中心Ib/II期临床研究由中国医学科学院肿瘤医院吴令英教授牵头，正在全国多家医院同步推进。该试验旨在评价奥帕替苏米单抗联合紫杉醇治疗铂耐药卵巢癌患者的疗效及安全性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维立志博-B(09887)：LBL-024于铂耐药卵巢癌IB/II期试验的首例患者用药","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887","HK0000252152.HKD","HK0000500386.USD","HK0000252160.HKD","BK1161"],"gpt_icon":0},{"id":"2593797465","title":"维立志博-B(09887)：LBL-047于I期试验的首例受试者用药","url":"https://stock-news.laohu8.com/highlight/detail?id=2593797465","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593797465?lang=zh_cn&edition=full","pubTime":"2025-12-23 12:26","pubTimestamp":1766463961,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B 发布公告，评价LBL-047安全性、耐受性、药代动力学╱药效动力学及初步临床有效性的I期临床研究首例受试者已成功用药。该I期研究为在健康成年人和系统性红斑狼疮患者中进行的随机、双盲、安慰剂对照、单剂量递增试验，旨在评估LBL-047的安全性、耐受性、药代动力学╱药效动力学及初步临床有效性。此外，LBL-047亦已通过Fc区改造延长半衰期得到优化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887","HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2593504664","title":"每日卖空追踪 | 维立志博-B 12月22日卖空量成交1.57万股，卖空比例为5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593504664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593504664?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392242,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月22日，跌1.39%，卖空量成交1.57万股，较上一交易日减少88.43%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163711a6c09ea1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163711a6c09ea1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","09887","BK1161"],"gpt_icon":0},{"id":"2593447450","title":"维立志博-B12月22日遭主力抛售36.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447450","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447450?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391342,"startTime":"0","endTime":"0","summary":"12月22日, 维立志博-B股价跌1.39%，报收49.50元，成交金额1412.8万元，换手率0.19%，振幅2.29%，量比0.64。维立志博-B今日主力资金净流出36.9万元，上一交易日主力净流出23.0万元。该股近5个交易日下跌4.81%，主力资金累计净流出121.6万元；近20日主力资金累计净流入342.1万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161928a6c088b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161928a6c088b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD","09887"],"gpt_icon":0},{"id":"2592119241","title":"每日卖空追踪 | 维立志博-B 12月19日卖空量成交1.6万股，卖空比例为2.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592119241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592119241?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133040,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月19日，跌0.69%，卖空量成交1.6万股，较上一交易日减少84.89%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163709a45f391c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163709a45f391c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","HK0000500386.USD","BK1161","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2592160898","title":"维立志博-B12月19日主力净流出23.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160898","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592160898?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132149,"startTime":"0","endTime":"0","summary":"12月19日, 维立志博-B股价跌0.69%，报收50.20元，成交金额2812.4万元，换手率0.37%，振幅3.52%，量比1.40。维立志博-B今日主力资金净流出23.0万元，上一交易日主力净流入44.0万元。该股近5个交易日下跌6.10%，主力资金累计净流出84.7万元；近20日主力资金累计净流入562.8万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162040a6b63353&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162040a6b63353&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","HK0000252152.HKD","HK0000500386.USD","BK1161","HK0000252160.HKD"],"gpt_icon":0},{"id":"2592559915","title":"每日卖空追踪 | 维立志博-B 12月17日卖空量成交1.5万股，卖空比例为3.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592559915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592559915?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960241,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月17日，跌0.97%，卖空量成交1.5万股，较上一交易日减少85.82%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163636a6ad27cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163636a6ad27cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","09887","BK1161","HK0000500386.USD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2592584915","title":"维立志博-B12月17日遭主力抛售1.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592584915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592584915?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959324,"startTime":"0","endTime":"0","summary":"12月17日, 维立志博-B股价跌0.97%，报收51.05元，成交金额2185.3万元，换手率0.28%，振幅2.72%，量比1.09。维立志博-B今日主力资金净流出1.4万元，上一交易日主力净流出104.3万元。该股近5个交易日下跌5.32%，主力资金累计净流出152.4万元；近20日主力资金累计净流出21.6万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161643a6ad1043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217161643a6ad1043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252160.HKD","HK0000500386.USD","HK0000252152.HKD","BK1161","09887"],"gpt_icon":0},{"id":"2591764679","title":"维立志博-B(09887)拟实施H股全流通计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2591764679","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591764679?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:42","pubTimestamp":1765802564,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B(09887)发布公告，于2025年12月15日，本公司已就拟实施H股全流通(H股全流通)向中国证监会提交备案材料，以转换合共4439.16万股本公司未上市股份(未上市股份)为本公司H股(占于本公告日期本公司已发行股本总额1.99亿股股份约22.32%)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","09887"],"gpt_icon":0},{"id":"2591264799","title":"每日卖空追踪 | 维立志博-B 12月15日卖空量成交1.86万股，卖空比例为6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591264799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591264799?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:30","pubTimestamp":1765787440,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月15日，跌2.35%，卖空量成交1.86万股，较上一交易日减少51.18%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163643a6a45a4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251215163643a6a45a4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","09887"],"gpt_icon":0},{"id":"2591686849","title":"每日卖空追踪 | 维立志博-B 12月12日卖空量成交2.47万股，卖空比例为7.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591686849","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591686849?lang=zh_cn&edition=full","pubTime":"2025-12-12 16:30","pubTimestamp":1765528239,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月12日，涨0.47%，卖空量成交2.47万股，较上一交易日减少56.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165851a4446e77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251212165851a4446e77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD","BK1161"],"gpt_icon":0},{"id":"2590333510","title":"智通港股投资日志|12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2590333510","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590333510?lang=zh_cn&edition=full","pubTime":"2025-12-12 00:00","pubTimestamp":1765468803,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年12月12日，港股上市公司投资日志如下：    类别 公司  新股活动智汇矿业(招股中)希迪智驾(招股中)HASHKEY HLDGS(招股中) 业绩公布日日光控股靛蓝星 股东大会召开日浩柏国际中食民安信利国际泸州银行深圳高速公路股份维立志博-B三花智控玄武云中信国际电讯诺科达科技 分红派息港通控股（除净日）完美医疗（除净日）义合控股（除净日）亚洲联合基建控股（除净日）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1380642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000500386.USD","HK0000252152.HKD","BK1161","09887","HK0000252160.HKD"],"gpt_icon":0},{"id":"2590213105","title":"维立志博-B12月11日遭主力抛售80.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590213105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590213105?lang=zh_cn&edition=full","pubTime":"2025-12-11 16:15","pubTimestamp":1765440952,"startTime":"0","endTime":"0","summary":"12月11日, 维立志博-B股价跌1.03%，报收53.00元，成交金额2185.8万元，换手率0.27%，振幅5.14%，量比0.59。维立志博-B今日主力资金净流出80.9万元，上一交易日主力净流出237.3万元。该股近5个交易日上涨0.19%，主力资金累计净流入52.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出108.9万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162105a6990c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251211162105a6990c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000252152.HKD","HK0000252160.HKD","BK1161","HK0000500386.USD","09887"],"gpt_icon":0},{"id":"2590390894","title":"港股异动 | 维立志博-B(09887)涨超3% LBL-034突破性数据于2025 ASH年会口头报告发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2590390894","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590390894?lang=zh_cn&edition=full","pubTime":"2025-12-09 14:37","pubTimestamp":1765262240,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维立志博-B涨超3%，截至发稿，涨2.39%，报53.6港元，成交额5125.77万港元。消息面上，维立志博-B发布公告，于2025年12月6日至9日，第67届ASH年会在美国佛罗里达州奥兰多召开。公司自主研发用于治疗复发性╱难治性多发性骨髓瘤的GPRC5D/CD3双特异性抗体LBL-034在大会首日第一个进行口头报告。2024年10月LBL-034获得FDA的孤儿药认定，用于治疗多发性骨髓瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252160.HKD","BK1161","09887","HK0000252152.HKD","BK4109","HK0000500386.USD","LU2463526074.USD","ASH"],"gpt_icon":0},{"id":"2590357319","title":"每日卖空追踪 | 维立志博-B 12月08日卖空量成交4.08万股，卖空比例为5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590357319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590357319?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182639,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月08日，涨1.26%，卖空量成交4.08万股，较上一交易日减少20.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163636979615dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163636979615dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","HK0000252152.HKD","HK0000252160.HKD","09887"],"gpt_icon":0},{"id":"2590357391","title":"ASH伴髓外病变ORR 100%，维立志博LBL-034或改写多发性骨髓瘤治疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2590357391","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590357391?lang=zh_cn&edition=full","pubTime":"2025-12-08 14:54","pubTimestamp":1765176840,"startTime":"0","endTime":"0","summary":"TCE赛道产业爆发，应用边界不断延伸，技术持续迭代。在今年的ASH年会上，维立志博的条件性激活的GPRC5D/CD3双抗LBL-034，凭借颠覆多发性骨髓瘤治疗的潜力，入选ASH年会首场口头汇报的首个重磅议题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081506199795e8d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512081506199795e8d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","HK0000500386.USD","BK1161","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0},{"id":"2589871029","title":"维立志博-B(09887)：LBL-034临床数据于第67届ASH年会发布","url":"https://stock-news.laohu8.com/highlight/detail?id=2589871029","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589871029?lang=zh_cn&edition=full","pubTime":"2025-12-07 18:28","pubTimestamp":1765103333,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维立志博-B 发布公告，于2025年12月6日至9日，第67届ASH年会在美国佛罗里达州奥兰多召开。公司自主研发用于治疗复发性╱难治性多发性骨髓瘤的GPRC5D/CD3双特异性抗体LBL-034在大会首日第一个进行口头报告。LBL-034的主要临床亮点包括：LBL-034剂量递增至1,200μg/kg，未观察到任何剂量限制性毒性，未达到最大耐受剂量。与生活质量密切相关不良事件均为1至2级，多数不良事件发生于第一周期，在后续治疗中的发生率显著降低，不影响治疗连续性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","LU2463526074.USD","HK0000500386.USD","09887","ASH","BK4109"],"gpt_icon":1},{"id":"2588838525","title":"每日卖空追踪 | 维立志博-B 12月04日卖空量成交4.02万股，卖空比例为7.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588838525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588838525?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837041,"startTime":"0","endTime":"0","summary":"维立志博-B北京时间12月04日，跌0.94%，卖空量成交4.02万股，较上一交易日减少80.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163647978f8911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163647978f8911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","HK0000252160.HKD","09887","HK0000252152.HKD"],"gpt_icon":0},{"id":"2588039756","title":"已达成超10亿美元合作，维立志博自免1类新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2588039756","media":"药渡","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588039756?lang=zh_cn&edition=full","pubTime":"2025-12-02 07:32","pubTimestamp":1764631937,"startTime":"0","endTime":"0","summary":"近日，中国国家药监局药品审评中心官网公示，维立志博生物申报的1类新药注射用LBL-047获批临床，拟开发治疗系统性红斑狼疮。值得一提的是，今年10月，维立志博宣布与Dianthus Therapeutics达成独家全球合作伙伴关系，共同推进LBL-047。维立志博将授予Dianthus在大中华区以外独家研发、生产及商业化LBL-047的权益，获得最高3800万美元的首付款及近期里程碑付款，其中包括2000万美元首付款、2025年第四季度支付的500万美元，以及最高1300万美元的潜在近期里程碑付款。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202091720a4c6c9a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202091720a4c6c9a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000500386.USD","09887","HK0000252160.HKD","HK0000252152.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leadsbiolabs.com","stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":0.002},{"period":"3month","weight":-0.1863},{"period":"6month","weight":0.46},{"period":"ytd","weight":0.46}],"compareEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.022},{"period":"3month","weight":-0.0281},{"period":"6month","weight":0.0596},{"period":"1year","weight":0.2963},{"period":"ytd","weight":0.2849}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"南京维立志博生物科技股份有限公司是一家主要从事发现、开发和商业化治疗肿瘤、自身免疫性疾病以及其他严重疾病的新疗法的中国公司。该公司的主要候选药物包括LBL-024、LBL-034、LBL-033、LBL-007等。该公司的LBL-024主要用于治疗肺外神经内分泌癌（EP-NEC）、小细胞肺癌（SCLC）、胆道癌（BTC）及非小细胞肺癌（NSCLC）、食管鳞状细胞癌（ESCC）、肝细胞癌（HCC）、胃癌（GC）及其他实体瘤。该公司还开发了专有技术平台，包括LeadsBody平台（CD3 T-cell engager平台）、X-body平台（4-1BB engager平台）以及其他几个双特异性抗体及融合蛋白平台。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"维立志博-B","nameEN":"LEADS BIOLABS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维立志博-B(09887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维立志博-B,09887,维立志博-B股票,维立志博-B股票老虎,维立志博-B股票老虎国际,维立志博-B行情,维立志博-B股票行情,维立志博-B股价,维立志博-B股市,维立志博-B股票价格,维立志博-B股票交易,维立志博-B股票购买,维立志博-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维立志博-B(09887)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维立志博-B(09887)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}